Therapeutic BCG Vaccines Market Poised to Hit $75.46 Billion by 2029 with Accelerating Growth Trends

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Therapeutic BCG Vaccines Market Size Growth Forecast: What to Expect by 2025?
In the past few years, the market size for therapeutic BCG vaccines has shown substantial growth. A progress is forecasted where the market that's currently valued at $56.47 billion in 2024 is likely to burgeon to $59.09 billion in 2025, depicting a Compound Annual Growth Rate (CAGR) of 4.6%. The historic growth rate of this market can be traced back to factors such as government-led TB control initiatives, modulation of the immune system, global vaccination initiatives, treatments for bladder cancer, investment in vaccine production, and the rise of drug-resistant strains of TB.

How Will the Therapeutic BCG Vaccines Market Size Evolve and Grow by 2029?
The market for therapeutic bcg vaccines is predicted to witness robust expansion in the coming years. By 2029, the market is projected to reach a value of $75.46 billion, growing at a compound annual growth rate (CAGR) of 6.3%. This growth during the forecast period is anticipated due to factors like expansion towards different indications, a rise in immunotherapy research, global initiatives against the rise of new infectious diseases, backing from regulatory bodies for vaccine development, and a focus on eliminating tuberculosis. Significant trends expected during this period include developments in vaccine technology, optimization of the supply chain, market consolidation along with partnerships, increased patient knowledge and awareness, alternative methods of delivery, and individualized medicine strategies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/therapeutic-bcg-vaccines-global-market-report

What Drivers Are Propelling the Growth of Therapeutic BCG Vaccines Market Forward?
The growth of the therapeutic BCG vaccine market is being accelerated by the increasing instances of tuberculosis (TB) across the globe. As an infectious ailment, TB predominantly affects the lungs and can be life-threatening. Its transmission can occur when infected individuals scatter bacterial droplets into the air through coughing or sneezing. BCG vaccines, which don't cause TB due to their weakened germ content, are employed to encourage the immune system to resist the infection. They provide reliable protection against the most severe forms of TB, such as adolescent TB meningitis. Because the BCG vaccine safeguards against TB and assists in infection combat, the consumption of therapeutic BCG vaccines is on the rise. For example, a report from the UK Health Security Agency published in February 2024 indicates that in 2023, TB instances in England surged by 10.7%, with 4,850 cases reported in comparison to 4,380 cases in 2022. Consequently, the surge in tuberculosis (TB) cases globally is fueling the growth of the therapeutic BCG vaccine market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9178&type=smp

What Are the Key Trends Driving Therapeutic BCG Vaccines Market Growth?
Key strategic collaborations appear to be a rising trend in the therapeutic BCG vaccine market. Major players in this market are seeking partnerships with leading companies to maintain their market standing. For instance, ImmunityBio, a biotechnology firm based in the US, partnered with the Serum Institute of India, another biotech and biopharmaceutical company, in May 2024 to guarantee a supply of the Bacillus Calmette-Guerin (BCG) vaccine for all forms of cancer. The core focus of this partnership is to produce the standard BCG (sBCG) approved for use outside the US, as well as a next-gen recombinant BCG (iBCG) which is currently undergoing testing. The iBCG is planned to be used alongside ImmunityBio's ANKTIVA (nogapendekin alfa inbakicept-PMLN) for approved and potential new uses, subject to regulatory nods.

What Are the Key Segments in the Therapeutic BCG Vaccines Market?
The therapeutic bcg vaccines market covered in this report is segmented -

1) By Type: Therapy BCG, Immune BCG
2) By Demographics: Pediatrics, Adults
3) By End Use: Hospitals, Clinics, Other End Users

Subsegments:
1) By Therapy BCG: Intravesical BCG, Injectable BCG
2) By Immune BCG: BCG For Immune Enhancement, BCG For Allergy Treatment

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9178&type=smp

Who Are the Key Players Shaping the Therapeutic BCG Vaccines Market's Competitive Landscape?
Major companies operating in the therapeutic bcg vaccines market include Merck & Co Inc., Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute of India Pvt. Ltd., InterVax Ltd., GreenSignal Bio Pharma Limited, Statens Serum Institute, AJ Vaccines, Bul Bio-National Center of Infectious and Parasitic Diseases Ltd, Biomed Lublin S.A., Microgen, Taj Pharma Ltd., PT Bio Farma, Torlak Institute of Virology, Bacille Bilie Calmette-Guerin Laboratory, China Biotechnology Co Ltd., Bharat Biotech International Ltd., Biological E. Limited, Shanghai Institute of Biological Products Co. Ltd., Cipla Limited, Instituto Butantan

What Geographic Markets Are Powering Growth in the Therapeutic BCG Vaccines Market?
Asia-Pacific was the largest region in the therapeutic BCG vaccines market in 2024. The regions covered in the therapeutic bcg vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9178

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.